Clin2
NCT06135636Possibly a fitRecruiting

Helping partners get the Tdap vaccine during pregnancy

Non-birthing Partner Vaccination in PregnancyTdap - Tetanus, Diphtheria and Acellular Pertussis VaccinationVaccine Exposure During Pregnancy

Part of Infections clinical trials.

This trial tests different ways to help partners of pregnant people get the Tdap vaccine (a shot that protects against tetanus, diphtheria, and whooping cough). The goal is to find the best way to increase vaccination rates among partners, which can help protect the newborn from whooping cough.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
150 people
Ages
19 years to 50 years
Study type
Interventional

Who can take part

  • You are the partner of a pregnant person who goes to the OGCC for prenatal care.
  • You are between 19 and 50 years old.
  • You haven't had the Tdap vaccine or booster in the last 10 years, or you're not sure.
  • You speak English or Spanish fluently.
  • You do not have a latex allergy.
  • The pregnancy does not have a diagnosed lethal fetal condition.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07097012Recruiting· Phase 4
Whooping cough and RSV vaccines: together or separate in pregnancy

This study tests whether giving two vaccines—one for whooping cough (Tdap) and one for RSV—at the same time is safe and effective compared to giving them separately during pregnancy. It may help protect your baby from both diseases early in life.

Vancouver, British Columbia
NCT06466629Recruiting
Best timing for the Tdap vaccine during pregnancy

This study tests when during pregnancy it is best to get the Tdap (whooping cough) vaccine. It aims to protect both mother and baby from whooping cough in the first months after birth.

Edegem, Antwerp
NCT07621341Not yet recruiting· Phase 4
Maternal Tetanus, Diphtheria, Pertussis Vaccine Study in Thai Pregnancies

This study tests whether giving pregnant women a special tetanus, diphtheria, and pertussis vaccine (TdaP2gen) helps protect their babies from these diseases. Researchers will follow mothers and infants for up to 18 months to measure how well the vaccine works.

Chiang Mai
NCT07596199Recruiting· Phase 3
Vaccine safety and immune response study in pregnant women

This study tests a vaccine that protects against three diseases—diphtheria, tetanus, and whooping cough—given during pregnancy. Researchers want to see if the vaccine is safe for pregnant women and their babies, and whether it helps protect newborns.

Chiba
NCT07112144Recruiting· Phase 3
DTaP vaccine trial for healthy infants aged 2 months

This trial tests a new vaccine that protects against diphtheria, tetanus, and pertussis (whooping cough). It is for healthy infants who are about 2 months old and live permanently in the area. The goal is to see if the vaccine is safe and works well.

Wenshan Zhuang and Miao Autonomous Prefecture, Yunnan
NCT07492303Not yet recruiting· Phase 1
Vaccine for adolescents and adults against whooping cough, diphtheria, tetanus

This trial tests a new combination vaccine that protects against whooping cough, diphtheria, and tetanus for people aged 10 and older. It aims to see if the vaccine is safe and helps the body build immunity.

Hear when a new Non-birthing Partner Vaccination in Pregnancy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.